After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SRRK falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Scholar Rock Holding Corp is $4.04B. A total of 0.89 million shares were traded on the day, compared to an average of 1.10M shares.
In the most recent transaction, Invus Public Equities, L.P. sold 1,600,000 shares of SRRK for 41.65 per share on Dec 10 ’24. After the transaction, the 10% Owner now owns 9,250,005 company shares. In a previous transaction on Nov 25 ’24, Invus Public Equities, L.P. sold 409,433 shares at 38.49 per share. SRRK shares that 10% Owner owns now total 10,850,005.
Among the insiders who sold shares, Marantz Jing L. disposed of 6,375 shares on Nov 25 ’24 at a per-share price of $39.44. This resulted in the CHIEF MEDICAL OFFICER holding 72,855 shares of SRRK after the transaction. In another insider transaction, Marantz Jing L. sold 2,145 shares at $30.01 per share on Nov 22 ’24. Company shares held by the CHIEF MEDICAL OFFICER now total 72,855.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SRRK has a high of $46.19 and a low of $6.76.
As of this writing, SRRK has an earnings estimate of -$0.58 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.49 per share and a lower estimate of -$0.65.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SRRK’s latest balance sheet shows that the firm has $252.99M in Cash & Short Term Investments as of fiscal 2021. There were $77.06M in debt and $64.30M in liabilities at the time. Its Book Value Per Share was $0.99, while its Total Shareholder’s Equity was $172.07M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRRK is Buy with a score of 5.00.